World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs, pp.12-1723, 2004. ,
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia, The American Journal of Surgical Pathology, vol.37, issue.10, pp.1469-89, 2013. ,
DOI : 10.1097/PAS.0b013e318299f2d1
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review, European Urology, vol.60, issue.4, pp.644-61, 2011. ,
DOI : 10.1016/j.eururo.2011.06.041
Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma, Journal of Clinical Oncology, vol.27, issue.5, pp.746-53, 2009. ,
DOI : 10.1200/JCO.2007.15.8345
Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma, Cancer, vol.67, issue.suppl 2, pp.5777-82, 2012. ,
DOI : 10.1002/cncr.27607
Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas, Human Pathology, vol.44, issue.10, pp.2106-2121, 2013. ,
DOI : 10.1016/j.humpath.2013.03.018
URL : https://hal.archives-ouvertes.fr/hal-00937633
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma, Clinical Cancer Research, vol.15, issue.24, pp.7582-7592, 2009. ,
DOI : 10.1158/1078-0432.CCR-09-2131
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review, Cancer Treatment Reviews, vol.34, issue.3, pp.193-205, 2008. ,
DOI : 10.1016/j.ctrv.2007.12.001
Immunotherapy for advanced renal cell cancer, Cochrane Database Syst Rev, issue.1, p.1425, 2005. ,
Current and future systemic treatments for renal cell carcinoma, Seminars in Cancer Biology, vol.23, issue.1 ,
DOI : 10.1016/j.semcancer.2012.06.004
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma, New England Journal of Medicine, vol.356, issue.22, pp.2271-81, 2007. ,
DOI : 10.1056/NEJMoa066838
Overexpression of the polarity protein PAR-3 in clear cell renal cell carcinoma is associated with poor prognosis, International Journal of Cancer, vol.135, issue.9, 2013. ,
DOI : 10.1002/ijc.28548
URL : https://hal.archives-ouvertes.fr/hal-01010658
The PAR-aPKC system: lessons in polarity, Journal of Cell Science, vol.119, issue.6, pp.979-87, 2006. ,
DOI : 10.1242/jcs.02898
Tight junctions and human diseases, Medical Electron Microscopy, vol.36, issue.3, pp.147-56, 2003. ,
DOI : 10.1007/s00795-003-0219-y
Par complex in cancer: a regulator of normal cell polarity joins the dark side, Oncogene, vol.74, issue.55, pp.6878-87, 2008. ,
DOI : 10.1158/0008-5472.CAN-05-4527
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis, Cancer Cell, vol.22, issue.5, pp.601-615, 2012. ,
DOI : 10.1016/j.ccr.2012.10.003
Loss of Par3 promotes breast cancer metastasis by compromising cell???cell cohesion, Nature Cell Biology, vol.11, issue.2, pp.189-200, 2013. ,
DOI : 10.1046/j.1365-2559.2002.14691.x
Expression of Partitioning Defective 3 (Par-3) for Predicting Extrahepatic Metastasis and Survival with Hepatocellular Carcinoma, International Journal of Molecular Sciences, vol.14, issue.1, pp.1684-97, 2013. ,
DOI : 10.3390/ijms14011684
Tumor Type-Dependent Function of the Par3 Polarity Protein in Skin Tumorigenesis, Cancer Cell, vol.22, issue.3, pp.389-403, 2012. ,
DOI : 10.1016/j.ccr.2012.08.004
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Annals of Surgical Oncology, vol.17, issue.6, pp.1471-1475, 2010. ,
DOI : 10.1245/s10434-010-0985-4
Toxicity and response criteria of the Eastern Cooperative Oncology Group, AMERICAN JOURNAL OF CLINICAL ONCOLOGY, vol.5, issue.6, pp.649-55, 1982. ,
DOI : 10.1097/00000421-198212000-00014
Interconversion of three measures of performance status: An empirical analysis, European Journal of Cancer, vol.46, issue.18, pp.3175-83, 2010. ,
DOI : 10.1016/j.ejca.2010.06.126
MULTI-INSTITUTIONAL VALIDATION OF A SYMPTOM BASED CLASSIFICATION FOR RENAL CELL CARCINOMA, The Journal of Urology, vol.172, issue.3, pp.858-62, 2004. ,
DOI : 10.1097/01.ju.0000135837.64840.55
A Comparative Analysis of FISH, RT-PCR, PCR, and Immunohistochemistry for the Diagnosis of Mantle Cell Lymphomas, Modern Pathology, vol.15, issue.5, pp.517-542, 2002. ,
DOI : 10.1038/modpathol.3880556
Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma, British Journal of Cancer, vol.94, issue.8, pp.1417-1441, 2009. ,
DOI : 10.1186/1471-2407-5-57
URL : https://hal.archives-ouvertes.fr/inserm-00418630
A Genome-Wide Screen for Microdeletions Reveals Disruption of Polarity Complex Genes in Diverse Human Cancers, Cancer Research, vol.70, issue.6, pp.2158-64, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-3458
Gene amplification of atypical PKC-bindingPARD3 in radiation-transformed neoplastic retinal pigment epithelial cell lines, Genes, Chromosomes and Cancer, vol.96, issue.1, pp.55-64, 2004. ,
DOI : 10.1002/gcc.20024
Renal tumors exhibiting granular cytoplasm, Semin Diagn Pathol, vol.16, issue.2, pp.135-180, 1999. ,
Epithelial-Mesenchymal Transitions in Development and Disease, Cell, vol.139, issue.5, pp.871-90, 2009. ,
DOI : 10.1016/j.cell.2009.11.007